NEW YORK, April 9, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc (BCLI). (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced ...
NEW YORK, Feb. 23, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback